story of the week
SGLT2 Inhibitor Use and the Risk of Dementia and Parkinson's Disease in Patients With Type 2 Diabetes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Neurology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
SGLT2 Inhibitor Use and Risk of Dementia and Parkinson Disease Among Patients With Type 2 Diabetes
Neurology 2024 Oct 22;103(8)e209805, HK Kim, GJ Biessels, MH Yu, N Hong, YH Lee, BW Lee, ES Kang, BS Cha, EJ Lee, M LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.